Research Papers

25 of 344 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Optical coherence tomography angiography-guided vs indocyanine green angiography-guided half-dose photodynamic therapy …
Li S; Zhang L; Tang J; Wang Z; Qu J; Zhao M.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Risk of visual axis opacification in infants with and without primary IOL implantation after congenital cataract surger…
Hložánek M; Cilečková L; Alió JL; Autrata R; Zelenayová N; Komínek M; Cendelín J; Mahelková G.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Refining vitrectomy for proliferative diabetic retinopathy.
Chen SN; Chen SJ; Wu TT; Wu WC; Yang CH; Yang CM.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Efficacy, durability, and safety of faricimab in patients from Asian countries with neovascular age-related macular deg…
Takahashi K; Cheung CMG; Iida T; Lai TYY; Ohji M; Yanagi Y; Kawano M; Ohsawa S; Suzuki T; Kotecha A; Lin H; Patel V; Swaminathan B; Lee WK; TENAYA; LUCERNE Investigators.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Developing and validating a questionnaire to assess the symptoms of blepharitis accompanied by dry eye disease.
Li H; Böhringer D; Maier P; Reinhard T; Lang SJ.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Ocular manifestations of obstructive sleep apnea: a systematic review and meta-analysis.
Bulloch G; Seth I; Zhu Z; Sukumar S; McNab A.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Safety of intracameral application of moxifloxacin and dexamethasone (Vigadexa®) after phacoemulsification surgery.
Galvis V; Prada AM; Tello A; Parra MM; Camacho PA; Polit MP.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The ideal intravitreal injection setting: office, ambulatory surgery room or operating theatre? A narrative review and …
Veritti D; Sarao V; Chhablani J; Loewenstein A; Lanzetta P; Società Italiana della Retina (SIR) Study Group; Intravitreal Injection Setting Study Group (I2SG).
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Artificial intelligence in retinal disease: clinical application, challenges, and future directions.
Daich Varela M; Sen S; De Guimaraes TAC; Kabiri N; Pontikos N; Balaskas K; Michaelides M.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Neurological pathologies in acute acquired comitant esotropia.
Nouraeinejad A.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
PRESERFLO ™ MicroShunt versus trabeculectomy: 1-year results on efficacy and safety.
Jamke M; Herber R; Haase MA; Jasper CS; Pillunat LE; Pillunat KR.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Complete blood count parameters as biomarkers of retinopathy of prematurity: a Portuguese multicenter study.
Fevereiro-Martins M; Santos AC; Marques-Neves C; Guimarães H; Bicho M; GenE-ROP Study Group.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
How to diagnose dry anophthalmic socket syndrome (DASS) in the clinical routine.
Rokohl AC; Trester M; Pine KR; Heindl LM.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The surge of acute angle-closure glaucoma during the outbreak of Omicron in a tertiary hospital in Shanghai.
Zhu M; Yan Y.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
2/6 Transparent
Keratoconus tomographic indices in osteogenesis imperfecta.
Correia Barão R; Santos M; Marques RE; Quintas AM; Guerra P.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Assessment of macular microvascular changes in children following treatment of anisometropic myopic amblyopia using opt…
AttaAllah HR; Abdelaziz STA; Mohamed AAM; Ibrahiem MFK.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Fundus autofluorescence abnormalities can predict fluorescein angiography abnormalities in patients with chronic centra…
Mohabati D; Boon CJF; Hoyng CB; Purtskhvanidze K; Roider J; van Dijk EHC.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Virtual supervision in ophthalmology: a scoping review.
Kang C; Shin CJ; Scott IU; Greenberg PB.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
2/6 Transparent
Favorable effect of ripasudil use on surgical outcomes of microhook ab interno trabeculotomy.
Okuda M; Mori S; Ueda K; Sakamoto M; Kusuhara S; Yamada-Nakanishi Y; Nakamura M.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
A rabbit model for outer retinal atrophy caused by surgical RPE removal.
Al-Nawaiseh S; Krötz C; Rickmann A; Strack C; Germann A; von Briesen H; Szurman P; Schulz A; Stanzel BV.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The PAUL® glaucoma implant: 1-year results of a novel glaucoma drainage device in a paediatric cohort.
Vallabh NA; Mohindra R; Drysdale E; Mason F; Fenerty CH; Yau K.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
2/6 Transparent
Benefit of intravitreal injections in patients with sub-threshold baseline visual acuity: a retrospective single-centre…
Grimm NA; Fahimi S; Kück F; Take P; Lauermann P; Nguyen-Hoehl A; Hoerauf H; Feltgen N; Bemme S.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The impact of case complexity in resident-performed cataract surgery.
Park SS; Tseng M; Mian Z; Moon JY; Shrivastava A.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The outcomes of a low-cost, non-valved glaucoma drainage device using mitomycin-C: 1-year results.
Awad-Allah MAA; Mousa AS; Ashour DM.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A novel quick contrast sensitivity function test in Chinese adults with myopia and its related parameters.
Ye Y; Aruma A; Zhao W; Lu ZL; Zhou X; Zhao J.
Graefes Arch Clin Exp Ophthalmol (Unknown)
Published: 2023
3/6 Transparent
Funding Declared